Clinical Trials at El Camino Hospital

El Camino Hospital is pleased to offer our patients the opportunity to participate in the latest research studies and have access to the latest treatments. We partner with pharmaceutical companies and device manufacturers, as well as major research organizations. If you are eligible and interested in a trial held at El Camino Hospital you can still continue to receive care right here in our community.

Clinical trials are used to develop, produce, and evaluate the effectiveness of new treatments and therapies for diseases. Participation in clinical trials is voluntary. Clinical trials are federally regulated. At El Camino Hospital they are also reviewed by the El Camino Hospital Institutional Review Board (IRB). The purpose of the IRB is to protect the patient. The IRB reviews all studies for safeguards and reasonable risks in relation to potential benefits.

Clinical trials are currently being conducted in the following areas:

Current Cancer Center Trials

• Breast Cancer
• Colorectal Cancer
• Improving Cancer Pain Management through Self-Care
• Kidney Cancer
  
• Lung Cancer
  
• Lung Cancer Detection Study - (REACT trial)
• MT Group Biobank Tissue Study
• Observation in Patients with Bone Metastasis Receiving Zometa Clinical Trial
• Symptom Clusters in Oncology Patients Receiving Chemotherapy

Norma Melchor Heart & Vascular Institute 

• EVERST II (REALISM)*
• CoreValve *

(*denotes trials that are managed by the Taft Center for Clinical Research at the Fogarty Institute for Innovation)

Neuroscience Institute - Parkinson's Disease

• Parkinson’s Progression Markers Initiative (PPMI)

Orthopedic

• XL TDR eXtreme Lateral Total Disc Replacement